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BACKGROUND: The diagnosis of tumors of soft tissue and bone (STB) heavily relies on histologi-
cal biopsies, whereas cytology is not widely used. CellientTM cell blocks often contain small tissue
fragments. In addition to Hematoxylin and Eosin (H&E) interpretation of histological features,
immunohistochemistry (IHC) can be applied after optimization of protocols. The objective of this
retrospective study was to see whether this cytological technique allowed us to make a precise
diagnosis of STB tumors.
METHODS: Our study cohort consisted of 20 consecutive STB tumors, 9 fine-needle aspiration
(FNAC) samples, and 11 endoscopic ultrasonography (EUS) FNACs and included 8 primary tumors
and 12 recurrences or metastases of known STB tumors.
RESULTS: In all 20 cases, H&E stained sections revealed that diagnostically relevant histological
and cytological features could be examined properly. In the group of 8 primary tumors, IHC per-
formed on CellientTM material provided clinically important information in all cases. For instance,
gastrointestinal stromal tumor (GIST) was positive for CD117 and DOG-1 and a PEComa showed
positive IHC for actin, desmin, and HMB-45. In the group of 12 secondary tumors, SATB2 was
visualized in metastatic osteosarcoma, whereas expression of S-100 was present in 2 secondary
chondrosarcomas. Metastatic chordoma could be confirmed by brachyury expression. Two
metastatic alveolar rhabdomyosarcomas were myf4 positive, a metastasis of a gynecologic leiomyo-
sarcoma was positive for actin and estrogen receptor (ER) and a recurrent dermatofibrosarcoma
protuberans expressed CD34.
CONCLUSION: In the proper clinical context, including clinical presentation with imaging studies,
the CellientTM cell block technique has great potential for the diagnosis of STB tumors.
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1 | INTRODUCTION
Soft tissue and bone (STB) tumors are rare malignancies, which com-
prise approximately 2% of all neoplasms. Because of this low incidence,
patients with STB tumors are usually referred to expert sarcoma cen-
ters, where multidisciplinary teams, according to well-established pro-
tocols and latest developments, can perform diagnostic procedures and
treatment. The clinical diagnosis of primary STB tumors relies on imag-
ing studies and an adequate biopsy. Imaging, in particular with
computed tomography (CT) and magnetic resonance imaging (MRI),
provides insight into the location, size, margins, and tissue composition
and heterogeneity of STB tumors. Although cytology has been applied
in just a few sarcoma centers,1–7 the primary diagnosis of STB tumors
is usually made on histological (needle or open) biopsies, since these
malignancies are morphologically heterogeneous and several histologi-
cal types have overlapping microscopic features. Moreover, for a con-
clusive diagnosis of STB tumors, additional immunohistochemistry
(IHC) and molecular pathology (fluorescent in situ hybridization (FISH),
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polymerase chain reaction (PCR), and next generation sequencing
(NGS)) often have to be administered, requiring special expertise.
Typing and grading of STB tumors is mandatory for treatment
decisions. In this clinical context, in our and most other sarcoma teams,
cytology is only applied in selected cases. Firstly, in cases with an
established diagnosis of the primary STB tumor, cytology can be effec-
tively used to diagnose recurrent or metastatic sarcoma. Secondly, for
deep-located STB tumors, cell material can be collected by fine-needle
aspiration (FNAC) during endoscopic ultrasonography (EUS-FNA) or by
endobronchial ultrasound-guided transbronchial needle aspiration
(EBUS). In our sarcoma team there is ample experience with these tech-
niques.2,4,8 Compared with histological biopsies, it is more easy to sam-
ple different tumor areas with fine-needle aspiration (FNA), and this may
result in increased diagnostic accuracy, in particular when dealing with
STBs with heterogeneous features on clinical imaging (CT and MRI).
Several different cell block methods can be used to process cell
material thus collected.9 As an adjunct to routinely prepared smears or
cell sediments, cytoblock techniques allow the application of IHC and
molecular methods, expanding the diagnostic armamentarium. For this
purpose, we and others8,10–14 have used the CellientTM automated cell
block system, by which cytotechnicians can make an automated cell
block within 1 hour, albeit with higher costs than that of traditional
cell block techniques. As described previously, with the CellientTM
method, using methanol fixation instead of formalin, a broad array of
diagnostically important antibodies can be applied to IHC after optimi-
zation of IHC protocols. In clinical cytology, the CellientTM method has
been used successfully for the characterization of tumor cells in serous
fluids and FNAC material, for example, to characterize different carci-
noma types or to diagnose metastatic melanoma.12
In this article, we report our first experience on the suitability of the
CellientTM method to diagnose several types of STB tumors, 8 primary
lesions (5 of which were gastrointestinal stromal tumors) and 12 second-
ary recurrences or metastases, applying 9 diagnostically relevant antibod-
ies that were not described in our earlier article of the CellientTM method.
2 | MATERIAL AND METHODS
2.1 | Ethics statement
The study met the criteria of the code of conduct for responsible use
of human tissue that is used in the Netherlands (Dutch federation of
biomedical scientific societies; http://www.federa.org).
TABLE 1 The 20 STB tumors included in this study
Primary tumor Localization Material Diagnostic antibodies Diagnosis
1 Stomach EUS CD117, DOG1 GIST
2 Stomach EUS CD117, DOG1 GIST
3 Peripancreatic EUS CD117, DOG1 GIST
4 Stomach EUS DOG1 GIST
5 Rectum EUS CD117, DOG1 GIST
6 Pararectal EUS Beta-catenin Desmoid fibromatosis
7 Rectum EUS Actin, desmin, HMB-45 PEComa
8 Retroperitoneum EUS Desmin, caldesmon, SMA Leiomyosarcoma
Secondary tumor Metastasis or recurrence of
1 Mediastinum EUS Desmin, ER Uterine leiomyosarcoma
2 Pancreas EUS SATB2 Osteosarcoma of bone
3 Mediastinum EUS S-100 Chondrosarcoma of bone
4 Inguinal node FNAC Brachyury Chordoma of sacrum bone
5 Inguinal node FNAC . . . Pleomorphic sarcoma NOS
6 Orbit FNAC myf4 Alveolar rhabdomyosarcoma
7 Cheek FNAC myf4 Alveolar rhabdomyosarcoma
8 Neck FNAC . . . Radiation-induced MPNST
9 Inguinal node FNAC . . . Pleomorphic sarcoma NOS
10 Paranasal FNAC CD-34 Dermatofibrosarcoma (DFSP)
11 Hip FNAC S-100 Chondrosarcoma of bone
12 Supraclavicular FNAC . . . Pleomorphic radiation sarcoma
Abbreviations: DFSP, dermatofibrosarcoma protuberans; GIST, gastrointestinal stromal tumor; MPNST, malignant peripheral nerve sheath tumor; NOS,
not otherwise specified.
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2.2 | Cell samples
Cell samples of aspirations from soft tissue and bone tumors processed
with the CellientTM processor (Hologic, Marlborough, Massachusetts)
between 2013 and 2016 were retrieved from the archives of the cytol-
ogy laboratory of the pathology department of University Medical Cen-
ter Groningen. Our cohort consisted of 20 consecutive cases, shown in
Table 1, and included 12 EUS guided aspirations of deep-seated tumors
(in the abdomen, retroperitoneal space, and mediastinum) and 9 FNAC
specimens of superficial lesions. All but 1 EUS guided aspirations were
performed with an EProCore needle (ECHO-HD-22-C; Echo Tip Ultra;
Cook Medical, Bloomington, Indiana). In all EUS procedures and most
FNAC aspirations, specimen cellularity had been checked on site by our
cytotechnicians and in case of low cellularity, repeated aspirations were
done. The study cohort comprised 16 soft tissue tumor cases (5 were
gastrointestinal stromal tumors) and 4 bone tumor cases (2 chondrosar-
comas and 2 osteosarcomas). For evaluation of diagnostic performance,
the cohort was divided in 2 groups, 8 primary lesions, and 12 secondary
lesions (metastases or recurrences of tumors of which the histologic
diagnosis was known). Histologic follow-up was available for all primary
tumors, allowing correlation of cytological and histological diagnosis.
2.3 | CellientTM cell block technique
Before being loaded into the CellientTM processor (Figure. 1A,B),
materials were washed in 1 mL CytolytTM Wash, centrifuged at
1000 g for 5 minutes, dissolved in 20 mL PreservCytTM fluid and
fixed for 20 minutes. One drop of the cell sediment was used to
FIGURE 1 A closer look at the CellientTM processor. Further details are found on the website: http://www.hologic.com/products/clinical-
diagnostics/instrument-systems/cellient-automated-cell-block-system [Color figure can be viewed at wileyonlinelibrary.com]
TABLE 2 The 14 antibodies applied with CellientTM cell block specimens
Antibody Clone type Clone Manufacturer Dilution Pretreatment
Actin-SMA Monoclonal 1A4 Ventana R.T.U No
Beta-catenin Monoclonal 14 Ventana R.T.U CC1 52 min
Brachyury Monoclonal EPR18113 Abcam 1:400 CC1 36 min
Caldesmon Monoclonal h-CD Dako 1:800 No
CD-117 Polyclonal C-KIT Dako 1:100 No
CD-34 Monoclonal QBEND10 Ventana R.T.U CC1 92 min
CK-AE1/3 Monoclonal AE1/AE3 Ventana R.T.U CC1 36 min1 protease 4 min
Desmin Monoclonal DE-R-11 Ventana R.T.U CC1 64 min
DOG1 Monoclonal SP 31 Ventana R.T.U. no
ER Monoclonal SP-1 Ventana R.T.U. No
HMB-45 Monoclonal HMB45 Ventana R.T.U No
myf-4 Monoclonal LO26 Monosan 1:25 CC1 64 min
S-100 Monoclonal 4C4.9 Ventana R.T.U No
SATB2 Monoclonal 4B10 Abcam 1:100 CC1 64 min
CC1, cell conditioning solution (Ventana), pre-treatment buffer, pH 8.4.
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prepare a Giemsa-stained smear. In addition, 6 drops of the cell sedi-
ment were washed for 20 minutes in 1 mL Cytolyt WashTM (Holo-
gic), a low-dose methanol-based solution used to lyse erythrocytes
and dissolve mucus. From this sediment, a Papanicolaou-stained
microscopic thin layer slide was prepared with the ThinPrep T5000
processor. The remaining part of the cell suspension was rinsed
twice in Cytolyt WashTM solution and centrifuged again for 5
minutes at 1200 g, after which the pellet was fixed with Preserv-
CytTM fluid for 20 minutes before the sample vial with PreservCytTM
was put in the automated CellientTM processor. The CellientTM
Automated Cell Block System is fully automated. It creates a
paraffin-embedded cell block in <1 hour by means of a controlled
vacuum that concentrates a layer of cells on a specially designed fil-
ter. Dehydrating and clearing reagents, including propranolol and
xylene, are vacuum-drawn through the sample, which is subse-
quently embedded in paraffin and finished in an additional layer of
paraffin; this makes it ready for histological sectioning. The vacuum-
assisted filtration concentrates available cells within the final paraf-
fin block. Eosin staining is used for visualization of the cell layer dur-
ing sectioning. During sectioning of the CellientTM cell blocks 10
paraffin sections of 4-mm thickness were prepared, and these were
mounted on aminopropyltriethoxysilane (APES)-coated microscopic
slides. One section was routinely stained with Hematoxylin and
Eosin (H&E) for microscopic evaluation of specimen cellularity. The
remaining unstained slides were available for IHC.
2.4 | Immunohistochemistry
The 14 antibodies (13 monoclonal, 1 polyclonal) applied in this
study, including their commercial source, clone, and working dilu-
tion, as summarized in Table 2. Five diagnostically relevant antibod-
ies had been evaluated in our earlier study of the CellientTM
method (CD117, AE1/3, ER, HMB-45, S-100). The 9 additional anti-
bodies used to diagnose the STB tumors in this cohort were actin,
beta-catenin, brachyury, caldesmon, CD-34, desmin, DOG-1, myf4,
and SATB2. All IHC stains were performed in the Benchmark Ultra
automated immunostainer (Ventana, Tuscon, Arizona) using the
Ultraview detection system and validated by testing proper dilution
of the antibody, need for CC1 antigen retrieval, and need for an 8
minutes amplification step in the IHC staining protocol, respectively
(Table 2). All antibodies had been tested with at least 3 different
CellientTM cell blocks prepared from 3 different specimens. IHC
results obtained with Cellient TM cell blocks were compared with
IHC results obtained with corresponding formalin-fixed, paraffin-
embedded (FFPE) tissue tumor material from the same patient as
reference standard. Several antibodies required antigen retrieval
with CC1 (cell conditioning buffer, pH 8.4) for optimal staining. CC1
with protease pretreatment proved to give to best results for cyto-
keratin antibody AE1–3. For all IHC staining, the Ventana Ultraview
DAB detection kit was used with an amplification step of 8 minutes.
Hematoxylin was used as a counterstain.
FIGURE 2 Microphotographs of H&E slides obtained from CellientTM cell blocks. (A) collagen rich tissue with fibroblastic tumor cells in
desmoid fibromatosis. (B) cartilaginous matrix with atypical hyperchromatic tumor cells in grade 2 chondrosarcoma. (C) pleomorphic tumor
cells in pleomorphic undifferentiated sarcoma. (D) hyperchromatic spindled tumor cells in malignant peripheral nerve sheath tumor (original
3200) [Color figure can be viewed at wileyonlinelibrary.com]
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3 | RESULTS
In all 20 cases, the H&E stained sections of the CellientTM material con-
tained small tissue fragments. H&E histology of these small tissue frag-
ments (microbiopsies) revealed that diagnostically relevant histological
and cytological features could be examined properly, as shown in Fig-
ure 2. Fragments of desmoid fibromatosis consisted of collagen rich tis-
sue with haphazardly arranged fibroblastic cells with round nuclei,
nucleoli, and tapering eosinophilic cytoplasm (Figure 2A). Fragments of
a grade 2 myxoid chondrosarcoma contained tumor cells with moder-
ately atypical, hyperchromatic, single and double nuclei embedded in
myxochondroid matrix (Figure 2B), whereas cellular fragments with
pleomorphic and hyperchromatic tumor cells were encountered in
recurrences of pleomorphic undifferentiated sarcoma and radiation
sarcoma (malignant peripheral nerve sheath tumor (MPNST)) (Figure
2C,D).
In the group of 8 primary tumors, we specifically diagnosed 5 spin-
dle cell gastrointestinal stromal tumors (GISTs) by positive IHC for both
CD117 and DOG-1. A PEComa of the rectum could be diagnosed after
positive IHC for actin, desmin and HMB-45, and a mesenteric desmoid
fibromatosis in a patient with familial adenomatosis polyposis (FAP)
syndrome showed focal nuclear positivity for beta-catenin, whereas a
retroperitoneal leiomyosarcoma was diagnosed as it showed expression
of the smooth muscle markers actin (SMA), desmin, and caldesmon.
Thus, in all primary STB tumors, IHC performed on CellientTM material
provided clinically important information.
In the group of 12 secondary tumors of known STB primaries, we
managed to confirm the presence of a local recurrence or metastasis in
FIGURE 3 Microphotographs of IHC using 12 diagnostically relevant antibodies with the CellientTM method. CD117 (A) and DOG-1 (B) in
GIST. Desmin (C) and HMB-45 (D) in PEComa. SMA (E) and caldesmon (F) in leiomyosarcoma. Nuclear staining of osteosarcoma cells with
SATB2 (G), S-100 (H) in chondrosarcoma, brachyury (I) in chordoma, myf4 (J) in alveolar rhabdomyosarcoma, and ER (K) in gynecologic leio-
myosarcoma. CD34 (L) in dermatofibrosarcoma protuberans (original 3200) [Color figure can be viewed at wileyonlinelibrary.com]
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all cases. This group included 4 bone sarcomas. A metastasis of an
osteosarcoma was positive for SATB2 and 2 secondary chondrosarco-
mas showed expression of S-100, whereas an inguinal lymph node
metastasis of a sacral chordoma was confirmed by IHC for the transcrip-
tion factor brachyury. The 8 secondary manifestations of soft tissue sar-
comas included 2 radiation-induced sarcomas and 2 pleomorphic
undifferentiated sarcomas (diagnosed solely on H&E morphology), 2
metastatic alveolar rhabdomyosarcomas (which were myf4 positive),
a metastatic leiomyosarcoma of the uterus (in which actin and ER
were positive), and a recurrent dermatofibrosarcoma protuberans
(CD34 positive). Thus, in addition to H&E morphology, in 8 out of
12 cases, IHC on CellientTM material provided incremental diagnos-
tic information.
In both groups (primary and secondary tumors), IHC results in Cel-
lient slides were concordant with those obtained in FFPE tumor biop-
sies or excisions/resections from the same patient.
Figure 3 depicts IHC results of all antibodies applied: CD117 (Figure
3A) and DOG-1 (Figure 3B) in GIST, desmin (Figure 3C) and HMB-45
(Figure 3D) in PEComa, SMA (Figure 3E) and caldesmon (Figure 3F) in
leiomyosarcoma, SATB2 in osteosarcoma (Figure 3G), S-100 in chondro-
sarcoma (Figure 3H), brachyury in chordoma (Figure 3I), myf4 in alveolar
rhabdomyosarcoma (Figure 3J), ER (Figure 3K) in metastatic gynecologic
leiomyosarcoma, and CD34 (Figure 3L) in dermatofibrosarcoma
protuberans.
4 | DISCUSSION
The CellientTM is a fully automated device that produces a cell block
within 1 hour based on a standardized protocol. This allows rapid diag-
nosis on the same day the specimen arrives in the lab instead of the fol-
lowing day, which is convenient in selected cases. A methanol-based
PreservCyt TM solution is used instead of formalin. Several research
groups have mentioned that the cellularity of CellientTM material is at
least comparable to that in traditional cell blocks, whereas cytomorpho-
logical details, in particular chromatin structure, appear to be bet-
ter.10,12,14 Advantages and disadvantages of commonly used cell block
methods including CellientTM have been amply reviewed by Jain et al.9
and are summarized in Table 3. We have noted that the CellientTM cell
blocks often contain small tissue fragments. In addition to H&E interpre-
tation of histological features, IHC and molecular methods, for example,
FISH or NGS, can be applied.8 In the cytology laboratory, immunostain-
ing can be applied to cell smears, ThinPrep specimens, cytospin speci-
mens, and cell blocks. In a UK NEQUAS quality control study, testing
commonly used antibodies for a diagnosis of carcinoma, mesothelioma,
melanoma, and lymphoma, it was found that the highest sensitivity was
provided by cell blocks, followed by cytospin specimens, liquid-based
cytology slides, and cell smears.15
Although cellular DNA and RNA are well preserved by methanol
fixation, at the protein level, IHC protocols that are routinely used for
FFPE material, have to be optimized and validated. We8 and Sauter
et al.13 have extensively tested many different antibodies for CellientTM
material using the automated Ventana Benchmark immunostainer. In
our initial study published in 2013, we showed that IHC performed on
CellientTM cell blocks could be applied to diagnostic algorithms that
proved to be helpful in the discrimination of major tumor types (carci-
noma, lymphoma, melanoma, and germ cell tumors), discrimination of
carcinoma subtypes (adenocarcinoma, squamous-cell carcinoma, and
neuroendocrine carcinoma), and determination of primary tumor site
(eg, lung and breast) in cases of metastatic carcinoma. Notably, in a con-
secutive series of 100 cases, additional and clinically relevant informa-
tion was obtained in 25% of serous fluid specimens and 29% of FNA
specimens.8
TABLE 3 Comparison of commonly used cell block methods, as reviewed by Jain et al.9
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Abbrevitions: FNA, fine needle aspiration; IHC, immunohistochemistry; LBC, liquid-based cytology.
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To our knowledge, this is the first report on the use of CellientTM
cell blocks for the diagnosis of soft tissue and bone tumors. We stress
that, in our and most sarcoma centers, cytology is only rarely applied
for diagnosing tumors of soft tissue and bone. For the tumors in this
series, EUS-FNA was tried to render a diagnosis of deep-seated pri-
mary tumors and FNA was used for superficially located metastatic or
recurrent tumors of which the histologic diagnosis was known. We
showed that by combining clinical presentation (including imaging stud-
ies), H&E morphology, and IHC, a diagnosis could be made in all 20
consecutive cases of tumors of soft tissue and bone. We evaluated 14
antibodies, 9 of which were not tested in our initial study. After optimi-
zation of factors influencing IHC results (in particular antigen retrieval
conditions, amplification steps in the detection system kit) we managed
to obtain excellent staining results for both cytoplasmic (eg, the smooth
muscle markers, actin, desmin, and caldesmon) as well as nuclear anti-
gens (eg, brachyury, myf4, and SATB2). In all 16 cases (all 8 primary
tumors and 8 secondary tumors) where IHC was applied, a specific
diagnosis could be made. For instance, brachyury, myf4, and SATB2,
which are markers for notochordial, myogenic, and osteoblastic cell dif-
ferentiation, respectively, allowed or confirmed a diagnosis of chor-
doma, alveolar rhabdomyosarcoma, and osteosarcoma.
Finally, cost considerations and budgetary constraints will deter-
mine the extent to which cytology laboratories use the rapid automated
processing or more time-consuming traditional manual FFPE method to
prepare cell blocks for H&E, IHC and/or FISH. Costs of the CellientTM
technique include purchase (50 000 US$) and reagents (10 US$ per
specimen). Although the cost of the CellientTM block technique is higher
than that of a traditional cell block technique, we estimated that saved
technician time is 30 minutes per specimen, using the time required to
prepare an agar cell block as a reference standard. However, in our
opinion, the cost of a new laboratory technique should be judged in the
context of total cost of patient health care, including reduction of other
diagnostic tests and patient life years saved, a cost analysis which is
beyond the scope of this article.
In summary, we have shown that routine H&E staining and IHC of
cell material processed with CellientTM processor has the potential to
accurately diagnose tumors of soft tissue and bone. In all 20 consecu-
tive cases, important clinical information was provided, which trans-
lated into improved patient care. However, due to the small sample
size, statistical analysis was not feasible, and a future study, testing
appropriate antibodies on a larger number of cases, is needed to assess
the real value of this method.
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